中国急救医学
中國急救醫學
중국급구의학
CHINESE JOURNAL OF CRITICAL CARE MEDICINE
2014年
12期
1090-1093
,共4页
右美托咪定%体外循环%二尖瓣置换术%心肌保护
右美託咪定%體外循環%二尖瓣置換術%心肌保護
우미탁미정%체외순배%이첨판치환술%심기보호
Dexmedetomidine%Extracorporeal circulation%Mitral valve replacement%Myocardial protection
目的:观察右美托咪定(dexmedetomidine, DEX)对二尖瓣置换术患者心肌的保护作用。方法入选的48例患者随机分为两组:DEX组( D组,25例)和生理盐水组( C组,23例)。D组给予DEX负荷量(0.5μg/kg,10 min泵注),泵注结束后开始麻醉诱导,并以0.5μg/(kg· h) DEX维持至手术结束;C组相同的方法泵注等容量的生理盐水。两组分别在麻醉诱导前( T0)、麻醉诱导后切皮前(T1)、体外循环开始时(T2)、体外循环结束时(T3)、停机后6 h(T4)5个时间点记录心率(HR)、平均动脉压(MAP)。在T1、T3、T4、停机后12 h(T5)、停机后24 h(T6)5个时间点采集血样测定血清肌钙蛋白I(cTnI)和缺血修饰白蛋白(IMA)。观察并记录两组患者手术时间、体外循环时间、主动脉阻闭时间、术后住院时间、心脏自动复跳率等临床指标。结果 D组在T1、T2时MAP明显高于C组(P<0.05)。 D组在T1、T2时HR明显低于C组(P<0.05)。 D组在T3、T4、T5、T6时cTnI水平均明显低于C组( P<0.05)。 D组IMA在T3、T4时明显低于C组( P<0畅05)。 D组自动复跳率明显高于C组( P<0.05)。结论 DEX能够稳定血流动力学,减轻二尖瓣置换术患者围术期心肌损伤,对心肌具有一定保护作用。
目的:觀察右美託咪定(dexmedetomidine, DEX)對二尖瓣置換術患者心肌的保護作用。方法入選的48例患者隨機分為兩組:DEX組( D組,25例)和生理鹽水組( C組,23例)。D組給予DEX負荷量(0.5μg/kg,10 min泵註),泵註結束後開始痳醉誘導,併以0.5μg/(kg· h) DEX維持至手術結束;C組相同的方法泵註等容量的生理鹽水。兩組分彆在痳醉誘導前( T0)、痳醉誘導後切皮前(T1)、體外循環開始時(T2)、體外循環結束時(T3)、停機後6 h(T4)5箇時間點記錄心率(HR)、平均動脈壓(MAP)。在T1、T3、T4、停機後12 h(T5)、停機後24 h(T6)5箇時間點採集血樣測定血清肌鈣蛋白I(cTnI)和缺血脩飾白蛋白(IMA)。觀察併記錄兩組患者手術時間、體外循環時間、主動脈阻閉時間、術後住院時間、心髒自動複跳率等臨床指標。結果 D組在T1、T2時MAP明顯高于C組(P<0.05)。 D組在T1、T2時HR明顯低于C組(P<0.05)。 D組在T3、T4、T5、T6時cTnI水平均明顯低于C組( P<0.05)。 D組IMA在T3、T4時明顯低于C組( P<0暢05)。 D組自動複跳率明顯高于C組( P<0.05)。結論 DEX能夠穩定血流動力學,減輕二尖瓣置換術患者圍術期心肌損傷,對心肌具有一定保護作用。
목적:관찰우미탁미정(dexmedetomidine, DEX)대이첨판치환술환자심기적보호작용。방법입선적48례환자수궤분위량조:DEX조( D조,25례)화생리염수조( C조,23례)。D조급여DEX부하량(0.5μg/kg,10 min빙주),빙주결속후개시마취유도,병이0.5μg/(kg· h) DEX유지지수술결속;C조상동적방법빙주등용량적생리염수。량조분별재마취유도전( T0)、마취유도후절피전(T1)、체외순배개시시(T2)、체외순배결속시(T3)、정궤후6 h(T4)5개시간점기록심솔(HR)、평균동맥압(MAP)。재T1、T3、T4、정궤후12 h(T5)、정궤후24 h(T6)5개시간점채집혈양측정혈청기개단백I(cTnI)화결혈수식백단백(IMA)。관찰병기록량조환자수술시간、체외순배시간、주동맥조폐시간、술후주원시간、심장자동복도솔등림상지표。결과 D조재T1、T2시MAP명현고우C조(P<0.05)。 D조재T1、T2시HR명현저우C조(P<0.05)。 D조재T3、T4、T5、T6시cTnI수평균명현저우C조( P<0.05)。 D조IMA재T3、T4시명현저우C조( P<0창05)。 D조자동복도솔명현고우C조( P<0.05)。결론 DEX능구은정혈류동역학,감경이첨판치환술환자위술기심기손상,대심기구유일정보호작용。
Objective To observe the protective effect of dexmedetomidine ( DEX ) on myocardium in patients with mitral valve replacement .Methods The selected patients were randomly divided into two groups:group DEX (group D, 25 cases) and saline group (group C, 23 cases).D group was given DEX load (0.5 g/kg, l0 min injection pump), start induction of anesthesia after pump, and 0.5 g/( kg· h) DEX until the end of operation .Group C used saline the same way pumping capacity.Heart rate (HR), mean arterial pressure (MAP) of the two groups were recorded at 5 time points:before induction of anesthesia (T0), after induction of anesthesia, before skin incision (T1), the beginning of cardiopulmonary bypass ( T2 ) , at the end of CPB ( T3 ) , 6 h after operation ( T4 ) . Blood samples were collected for determination of serum troponin I ( cTnI ) and ischemia modified albumin (IMA) in the T1, T3, T4, 12 h after operation (T5), 24 h after operation (T6) 5 time points.Operation time, cardiopulmonary bypass time, aortic blocking time, postoperative hospitalization time, automatic rebeating rate and other clinical indicators between the two groups were also recorded . Results MAP in group D before skin incision ( T1 ) , the beginning of cardiopulmonary bypass ( T2 ) while was higher than that in group C , the difference was statistically significant ( P<0.05 ) .HR in group D before skin incision ( T1 ) , the beginning of cardiopulmonary bypass ( T2 ) was significantly lower than that in C group, the difference was statistically significant (P<0.05).The cTnI levels of D group at the end of CPB ( T3 ) , 6 h after operation ( T4 ) , 12 h ( T5 ) , 24 h ( T6 ) were significantly lower than those in C group, the difference was statistically significant (P<0.05).IMA of group D at the end of CPB ( T3 ) , 6 h after operation ( T4 ) was significantly lower than that in C group , the difference was statistically significant (P<0.05).Automatic rebeating rate in D group was significantly higher than that of C group , the difference was statistically significant ( P <0 .05 ) .Conclusion Dexmedetomidine can stabilize the hemodynamics , reduce myocardial injury during perioperative period in patients with mitral valve replacement , has certain protective effect on myocardial .